Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click here to see what happened.
pixel

ADMP Insider Trading (Adamis Pharmaceuticals)

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $70,646.40

Adamis Pharmaceuticals Insider Trading History Chart

Adamis Pharmaceuticals Share Price & Price History

$1.12
▲ +0.01 (0.90%)
As of 02/26/2021 01:00 AM ET
Days: 30 | 90 | 365
The END of Capitalism As We Know It?
A terrifying (for some) and new disruptive force is creating thousands of new millionaires (Barron’s reports 20,000 to 200,000 so far) while at the same time destroying the financial future for many others.
Don’t get left behind. Get the facts for yourself

Adamis Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2020David J MarguglioSVPSell35,000$0.40$14,000.00287,264  
9/29/2020Robert O HopkinsCFOSell20,000$0.80$16,000.00274,781  
8/18/2020David J. MarguglioSVPSell8,749$0.87$7,611.63  
8/18/2020Dennis J. Phd CarloCEOSell10,929$0.87$9,508.23  
8/18/2020Karen K. DanielsVPSell5,480$0.87$4,767.60  
8/18/2020Robert O. HopkinsCFOSell7,418$0.87$6,453.66  
3/18/2020Dennis J Phd CarloCEOSell10,645$0.34$3,619.30320,089  
3/18/2020Karen K DanielsVPSell6,461$0.34$2,196.74150,999  
3/18/2020Robert O HopkinsCFOSell8,749$0.34$2,974.66308,731  
3/18/2020Ronald B MossInsiderSell10,337$0.34$3,514.58242,858  
2/24/2020David J MarguglioSVPSell9,948$0.60$5,968.80335,359  
2/24/2020Dennis J Phd CarloCEOSell12,436$0.60$7,461.60330,734  
2/24/2020Karen K DanielsVPSell6,229$0.60$3,737.40157,460  
2/24/2020Robert O HopkinsCFOSell8,420$0.60$5,052.00317,480  
11/18/2019David J MarguglioSVPSell8,283$0.87$7,206.21365,307  
11/18/2019Dennis J Phd CarloCEOSell10,760$0.84$9,038.40343,170  
11/18/2019Karen K DanielsVPSell5,421$0.83$4,499.43163,689  
11/18/2019Robert O HopkinsCFOSell7,347$0.83$6,098.01325,900  
11/18/2019Ronald B MossInsiderSell8,448$0.85$7,180.80259,424  
8/19/2019David J MarguglioSVPSell8,109$1.10$8,919.90373,590  
8/19/2019Dennis J Phd CarloCEOSell10,477$1.06$11,105.62353,930  
8/19/2019Karen K DanielsVPSell5,243$1.06$5,557.58169,110  
8/19/2019Robert O HopkinsCFOSell7,101$1.06$7,527.06333,247  
8/19/2019Ronald B MossInsiderSell8,383$1.06$8,885.98267,872  
5/24/2019Robert B RothermelDirectorBuy6,500$1.58$10,270.00133,500  
5/20/2019David J MarguglioSVPSell8,735$1.77$15,460.95381,699  
5/20/2019Dennis J Phd CarloCEOSell11,184$1.73$19,348.32364,407  
5/20/2019Karen K DanielsVPSell5,591$1.73$9,672.43174,353  
5/20/2019Robert O HopkinsCFOSell7,559$1.73$13,077.07340,348  
5/20/2019Ronald B MossInsiderSell8,741$1.77$15,471.57276,255  
3/20/2019David J MarguglioSVPSell10,579$2.28$24,120.12390,434  
3/20/2019Dennis J Phd CarloCEOSell13,292$2.27$30,172.8442,353  
3/20/2019Karen K DanielsVPSell13,911$2.30$31,995.30179,944  
3/20/2019Robert O HopkinsCFOSell8,900$2.30$20,470.00347,907  
3/20/2019Ronald B MossInsiderSell6,647$2.27$15,088.69284,996  
See Full Table

SEC Filings (Institutional Ownership Changes) for Adamis Pharmaceuticals (NASDAQ:ADMP)

7.36% of Adamis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adamis Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/12/2021Verdence Capital Advisors LLC58,382$28K0.0%-33.9%0.065%
2/4/2021GSA Capital Partners LLP516,203$0.25M0.0%+825.9%0.573%
12/11/2020Virtu Financial LLC39,683$31K0.0%N/A0.044%
11/9/2020Verdence Capital Advisors LLC88,382$69K0.0%N/A0.098%
11/6/2020GSA Capital Partners LLP55,752$44K0.0%N/A0.062%
11/2/2020Level Four Advisory Services LLC32,000$25K0.0%-40.2%0.036%
10/29/2020Cambridge Investment Research Advisors Inc.46,849$37K0.0%N/A0.052%
7/31/2020UBS Group AG61,575$33K0.0%+426.3%0.083%
5/15/2020Sabby Management LLC88,210$32K0.0%N/A0.121%
2/20/2020Geode Capital Management LLC629,742$0.44M0.0%+86.8%1.022%
10/17/2019Wedbush Securities Inc.86,600$61K0.0%+94.2%0.141%
8/16/2019First Manhattan Co.1,391,733$1.81M0.0%-58.5%2.265%
8/14/2019Morgan Stanley757,124$0.98M0.0%+189.7%1.589%
8/14/2019Vanguard Group Inc.1,791,266$2.33M0.0%+4.5%3.760%
8/14/2019A.R.T. Advisors LLC61,711$80K0.0%+143.8%0.130%
8/13/2019BlackRock Inc.962,687$1.25M0.0%+1.5%2.021%
8/6/2019GSA Capital Partners LLP139,605$0.18M0.0%N/A0.293%
8/1/2019Wedbush Securities Inc.44,600$58K0.0%+139.8%0.094%
6/30/2019Leisure Capital Management22,311$29K0.0%-80.7%0.047%
5/10/2019DekaBank Deutsche Girozentrale1,200,000$3.36M0.0%N/A2.537%
5/8/2019National Asset Management Inc.29,920$64K0.0%+28.9%0.063%
5/8/2019Leisure Capital Management115,724$0.24M0.2%+4.5%0.245%
4/17/2019Wedbush Securities Inc.18,600$39K0.0%N/A0.039%
4/12/2019Virtu Financial LLC20,588$43K0.0%N/A0.044%
4/12/2019First Manhattan Co.3,352,333$7.07M0.0%-2.0%7.089%
2/15/2019Jane Street Group LLC13,740$31K0.0%N/A0.029%
2/14/2019Barclays PLC48,700$0.11M0.0%N/A0.103%
2/13/2019Geode Capital Management LLC301,330$0.68M0.0%+18.9%0.637%
2/12/2019Northern Trust Corp166,170$0.37M0.0%-2.0%0.351%
2/11/2019Raymond James Financial Services Advisors Inc.14,317$32K0.0%-28.9%0.030%
2/11/2019Raymond James & Associates49,596$0.11M0.0%+56.5%0.105%
2/8/2019BlackRock Inc.963,864$2.17M0.0%+8.4%2.038%
2/7/2019LPL Financial LLC15,490$35K0.0%-31.4%0.033%
2/5/2019Cambridge Investment Research Advisors Inc.16,001$36K0.0%N/A0.034%
1/29/2019Oppenheimer & Co. Inc.17,000$38K0.0%N/A0.036%
12/13/2018Vanguard Group Inc1,637,513$5.73M0.0%+27.1%3.463%
11/23/2018Vanguard Group Inc.1,637,513$5.73M0.0%+27.1%3.463%
11/14/2018Perceptive Advisors LLC137,500$0.48M0.0%N/A0.291%
11/9/2018DekaBank Deutsche Girozentrale1,200,000$3.36M0.0%+71.4%2.538%
11/9/2018BlackRock Inc.889,440$3.11M0.0%+203.2%1.881%
11/9/2018Leisure Capital Management120,940$0.42M0.3%-23.1%0.256%
10/15/2018First Manhattan Co.3,419,269$11.97M0.1%N/A7.230%
10/3/2018Acropolis Investment Management LLC30,000$0.11M0.0%N/A0.063%
8/9/2018BlackRock Inc.293,328$0.94M0.0%+7.7%0.878%
5/11/2018Dimensional Fund Advisors LP69,790$0.24M0.0%N/A0.209%
5/9/2018Northern Trust Corp139,536$0.49M0.0%+50.7%0.418%
2/10/2018B. Riley Financial Inc.232,228$1.02M0.3%N/A0.696%
2/9/2018Virtu Financial LLC100,363$0.44M0.0%N/A0.301%
2/8/2018Wells Fargo & Company MN28,182$0.12M0.0%+1,050.3%0.084%
11/8/2017EAM Investors LLC371,732$1.94M0.3%+58.3%1.186%
11/8/2017Granite Investment Partners LLC87,611$0.46M0.0%N/A0.279%
11/6/2017Bank of New York Mellon Corp27,464$0.14M0.0%+131.0%0.088%
11/6/2017Advisor Group Inc.56,001$0.29M0.0%+149.9%0.179%
8/15/2017Stonebridge Capital Advisors LLC27,500$0.14M0.0%+22.2%0.100%
8/14/2017DAFNA Capital Management LLC24,401$0.13M0.1%-18.7%0.089%
8/14/2017First Allied Advisory Services Inc.22,000$0.11M0.0%N/A0.080%
8/11/2017Virtu KCG Holdings LLC38,474$0.20M0.0%+103.2%0.140%
8/11/2017EAM Investors LLC234,762$1.22M0.2%N/A0.852%
8/11/2017Vanguard Group Inc.942,940$4.90M0.0%+22.2%3.421%
8/10/2017Bard Associates Inc.153,050$0.80M0.4%No Change0.555%
8/10/2017Wells Fargo & Company MN32,500$0.17M0.0%N/A0.118%
8/9/2017Leisure Capital Management145,909$0.76M0.7%+7.2%0.529%
8/2/2017Sterling Global Strategies LLC70,934$0.37M1.8%+66.5%0.257%
7/31/2017IFP Advisors Inc34,433$0.18M0.0%+2,245.6%0.125%
7/28/2017State of New Jersey Common Pension Fund D29,338$0.15M0.0%No Change0.106%
5/12/2017Bard Associates Inc.153,050$0.65M0.3%-1.9%0.000%
5/12/2017Axiom International Investors LLC DE97,040$1.70M0.0%N/A0.000%
5/12/2017Sterling Global Strategies LLC42,600$0.18M0.9%+6.5%0.000%
5/10/2017Leisure Capital Management136,077$0.58M0.5%-2.6%0.000%
4/26/2017State of New Jersey Common Pension Fund D29,338$0.13M0.0%No Change0.130%
2/14/2017Bard Associates Inc.156,000$0.49M0.2%-1.3%0.723%
2/10/2017Sterling Global Strategies LLC40,000$0.13M0.5%+90.5%0.185%
11/15/2016Sio Capital Management LLC665,455$2.28M1.6%-2.8%3.186%
11/1/2016Leisure Capital Management137,132$0.47M0.4%N/A0.657%
1/13/2016Creative Planning0$00.0%-100.0%0.000%
Data available starting January 2016

See Full Table
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.
Read More

Today's Range

Now: $1.12
$1.05
$1.17

50 Day Range

MA: $1.23
$0.70
$1.79

52 Week Range

Now: $1.12
$0.27
$2.34

Volume

5,516,180 shs

Average Volume

29,300,738 shs

Market Capitalization

$150.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Who are the company insiders with the largest holdings of Adamis Pharmaceuticals?

Adamis Pharmaceuticals' top insider investors include:
  1. David J Marguglio (SVP)
  2. Dennis J Phd Carlo (CEO)
  3. Robert O Hopkins (CFO)
  4. Ronald B Moss (Insider)
  5. Karen K Daniels (VP)
  6. Robert B Rothermel (Director)
  7. David J Marguglio (SVP)
  8. Dennis J Phd Carlo (CEO)
  9. Karen K Daniels (VP)
  10. Robert O Hopkins (CFO)

Who are the major institutional investors of Adamis Pharmaceuticals?

Adamis Pharmaceuticals' top institutional shareholders include:
  1. GSA Capital Partners LLP — 0.57%
  2. Verdence Capital Advisors LLC — 0.06%

Which major investors are selling Adamis Pharmaceuticals stock?

Within the previous quarter, ADMP stock was sold by these institutional investors:
  1. Verdence Capital Advisors LLC
During the last year, company insiders that have sold Adamis Pharmaceuticals company stock include:
  1. David J Marguglio (SVP)
  2. Dennis J Phd Carlo (CEO)
  3. Robert O Hopkins (CFO)
  4. Ronald B Moss (Insider)
  5. Karen K Daniels (VP)
  6. Robert B Rothermel (Director)
  7. David J Marguglio (SVP)
  8. Dennis J Phd Carlo (CEO)
  9. Karen K Daniels (VP)

Which major investors are buying Adamis Pharmaceuticals stock?

In the previous quarter, ADMP stock was bought by institutional investors including:
  1. GSA Capital Partners LLP
Buy This Ticker Now: Projected To Jump 1,530%
With experts projecting gains as high as 1,530% by the end of this year…

Forbes has already confirmed that when all is said and done, "a new class of millionaires may emerge."
Click here and get the ticker… no strings attached